Paper466930
Kinetics of a new antimalarial, mefloquine.
Desjardins RE and 4 others. Clin Pharmacol Ther, 1979. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Kinetics of a new antimalarial, mefloquine. Papers, record 466930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/466930
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Quinolines | Major topic |
| Adult | |
| Humans | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Piperidines |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38837364 | The human malaria-Aotus monkey model: a historical perspective in antimalarial chemotherapy research at the Gorgas Memorial Laboratory-Panama. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/38837364 | PubMed |
| 33995308 | Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33995308 | PubMed |
| 32521771 | Pharmacokinetic Profile of Oral Administration of Mefloquine to Clinically Normal Cats: A Preliminary In-Vivo Study of a Potential Treatment for Feline Infectious Peritonitis (FIP). | Animals (Basel) | 2020 | https://conductscience.org/library/papers/32521771 | PubMed |
| 32287278 | In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula). | PLoS One | 2020 | https://conductscience.org/library/papers/32287278 | PubMed |
| 30198595 | Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/30198595 | PubMed |
| 26891915 | The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review. | Malar J | 2016 | https://conductscience.org/library/papers/26891915 | PubMed |
| 26732683 | Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya. | Malar J | 2016 | https://conductscience.org/library/papers/26732683 | PubMed |
| 24550329 | Discovery of compounds blocking the proliferation of Toxoplasma gondii and Plasmodium falciparum in a chemical space based on piperidinyl-benzimidazolone analogs. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24550329 | PubMed |
| 20922425 | Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum. | Parasitol Res | 2011 | https://conductscience.org/library/papers/20922425 | PubMed |
| 20015395 | Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children. | Malar J | 2009 | https://conductscience.org/library/papers/20015395 | PubMed |
| 19216790 | Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. | Genome Biol | 2009 | https://conductscience.org/library/papers/19216790 | PubMed |
| 18532880 | Gametogenesis in malaria parasites is mediated by the cGMP-dependent protein kinase. | PLoS Biol | 2008 | https://conductscience.org/library/papers/18532880 | PubMed |
| 17216435 | Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment. | Eur J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17216435 | PubMed |
| 17178798 | Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17178798 | PubMed |
| 7957448 | Pharmacokinetic study of mefloquine in Thai children aged 5-12 years suffering from uncomplicated falciparum malaria treated with MSP or MSP plus primaquine. | Eur J Drug Metab Pharmacokinet | 1994 | https://conductscience.org/library/papers/7957448 | PubMed |
| 7859199 | Adverse reaction to mefloquine associated with ethanol ingestion. | CMAJ | 1995 | https://conductscience.org/library/papers/7859199 | PubMed |
| 7682911 | Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. | Drugs | 1993 | https://conductscience.org/library/papers/7682911 | PubMed |
| 7677878 | Malaria prophylaxis. Toxicity of mefloquine is similar to that of other chemoprophylaxis. | BMJ | 1995 | https://conductscience.org/library/papers/7677878 | PubMed |
| 6780117 | Brain death in three neurosurgical units. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6780117 | PubMed |
| 6610555 | The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6610555 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/466930
GET https://conductscience.org/api/papers/v1/466930/cited_by?page=2